Morningstar

Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences

Provided by Business Wire

Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

  • Wolfe Research Healthcare Conference on Tuesday, November 10 at 11:20 AM Eastern Time
  • UBS Global Biopharma Conference on Tuesday, November 17 at 10:00 AM Greenwich Mean Time
  • Jefferies Global Healthcare Conference on Tuesday, November 17 at 2:30 PM Greenwich Mean Time
  • Citi’s Global Healthcare Conference on Tuesday, December 1 at 11:00 AM Eastern Time
  • Annual Evercore Healthcare Conference on Wednesday, December 2 at 11:40 AM Eastern Time

The live webcasts can be accessed on the company’s investor relations website at investors.gilead.com. The replays will be available for at least 30 days following each presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Jacquie Ross, CFA – Investors
investor_relations@gilead.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20261030499668/en/

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

5 Stocks to Buy Trading at Big Discounts

Plus, what recent bond market volatility means for investors.
David Sekera, CFA and Sarah Hansen

This Once-Hot AI Stock Now Looks Deeply Undervalued

This chip stock looks cheap at a 30% discount, and its biggest growth years could still be ahead.
William Kerwin, CFA

What 7 Key Market Indicators Are Telling Investors Right Now

US equity valuations have retreated from their recent highs, but all 7 major market indicators remain above their long-term averages.
Amy C. Arnott, CFA

Don’t Overlook the Income Side of Fixed Income

Amid bond market tumult, elevated yields are contributing to returns and offering investors a nice income stream.
Dan Lefkovitz

2 Undervalued AI Stocks With Room to Run

What the next phase of the AI boom could mean for these two companies, and why we see upside ahead.
David Sekera, CFA, Sarah Hansen, and Jess Bebel

Sponsor Center